This study investigated the frequency and patterns of apraxic deficits and their association with cognitive impairment in 63 patients with biomarker-verified Alzheimer’s pathology, i.e. patients with abnormal amyloid-β and tau protein levels (A +/T +) in the CSF or PET imaging. Here, MAPT is linked to Cognitive impairment.